Europe PMC
open access
Engineering immune cell engagers: From molecular constructs to biomaterial platforms
Immune cell engagers (ICEs) are emerging therapeutic platforms that redirect immune effector cells toward cancer cells by physically bridging immune-cell receptors with tumor-associated targets. This cell-bridging mechanism converts molecular recognition into localized immune activation, immune syna
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Immunometabolism and rheumatic disease-advancing targeted therapies#1204006
- Cell State Dependent Strategies for Resolving Fundamental Properties of Ligands Via Receptor Processes#220312
- Targeted delivery of mRNA to immune cells for#455650
- Antibody-Antigen Interaction#957487
- Antibody-Antigen Interaction#957486
Record · ID 1414826
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive